Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
leukemia
Leukeran
leuprolide Leuprolide Prostate Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
Leustatin
Libtayo
liposomal irinotecan
lisocabtagene maraleucel Lisocabtagene maraleucel Lymphoma Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
liso-cel
L-leucovorin Colorectal Cancer Osteogenic Sarcoma
lomustine Brain Cancer Lomustine Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
loncastuximab
loncastuximab tesirine Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
loncastuximab tesirine-lpyl
Lonsurf
lorazepam Common Regimens for Chemotherapy-Induced Nausea and Vomiting Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting:
Lorbrena
lorlatinib Lorlatinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
LOXO-305
L-PAM
Lumakras
Lumoxiti
lung cancer
Lunsumio
Lupron
lurbinectedin Lurbinectedin Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
luspatercept
Lutathera
lutetium Lu 177 dotatate Carcinoid Tumors and Neuroendocrine Tumors Lurbinectedin Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
LV5FU2
LY231514